Isoniazid is a first-line antibiotic used in the prevention and treatment of tuberculosis. It is currently the subject of various clinical trials for use in preventing TB in HIV-infected patients, who have a high risk of contracting the infection.
Copyright © 2012 American Chemical Society
Log In